Kim’s public health blog

In a study published this week in the Archives of Internal Medicine we find Diabetes mellitus is common, costly, and increasingly prevalent. Despite innovations in therapy, little is known about patterns and costs of drug treatment. Further, increasingly complex and costly diabetes treatments are being applied to an increasing population. The magnitude of these rapid changes raises concerns about whether these more costly therapies will result in proportionately improved outcomes. Comment: We may have we reached a point for chronic diseases where there is too much research on technology, and too little understanding of how the interventions affect the disease.